Unknown Medication May Provide Hope For Countless Autoimmune Patients - LDN Documentary


First published at 22:20 UTC on June 2nd, 2018.

Several researchers and doctors believe LDN can have an effect on Alzheimer's, Parkinson's, various cancers, psoriasis, MS and all 170 other autoimmune diseases and conditions. But doctors are not aware of the drug.

This is a wonderful documentary short about Low Dose Naltrexone (LDN), a very inexpensive drug licensed in the 80's for opiate addiction. The usage of this drug at very low dosages has proven very helpful for treating autoimmune disease.

I myself have been taking LDN for several years and I credit it with saving my life. I've documented my journey with LDN on the Facebook Page: My LDN Journey https://www.facebook.com/MyLDNJourney

Naltrexone is a drug that was approved by the FDA in 1985 to treat opiate dependence. It is marketed under the trade names, ‘Revia®’ and ‘Depade®’, and in some countries (including the United States), an extended‐release formulation is available as ‘Vivitrol®’. Naltrexone is commonly used at a dose of 50mg–100mg daily for treating opiate dependence.

The term ‘LDN’ refers to the use of naltrexone at low doses; specifically between 3mg and 10mg per day (although most users experience best results with 1.5 mg-4.5mg). Naltrexone exhibits novel and paradox effects when administered as these low doses, as discovered by Dr. Ian S. Zagon and his team at Hershey Medical Center, Penn State University in 1980.

Low Dose Naltrexone (LDN) & Autoimmune Disorders

LDN is being used as a regulator of the immune system, providing relief to patients with autoimmune diseases, and central nervous system disorders. Physicians are permitted to prescribe LDN ‘off‐label’ for any use they think is appropriate. The apparently diverse conditions in which LDN appears to have a therapeutic effect are united by their ability to benefit from increased levels of endorphins (naturally occurring opioids – specifically OGF). The theory is that LDN may stimulate the pituitary to increase the production and release of endorphins.

The therapeutic dosage range for LDN is from 1.5mg to 4.5mg every night. Dosages below this range are likely to have no effect at all, and dosages above this range are likely to block endorphins for too long a period of time and interfere with its effectiveness.

Warning! Those patients who are taking thyroid hormone replacement for a diagnosis of Hashimoto’s thyroiditis with hypothyroidism ought to begin LDN at the lowest range (1.5mg for an adult).

Be aware that LDN may lead to a prompt decrease in the autoimmune disorder, which then may require a rapid reduction in the dose of thyroid hormone replacement in order to avoid symptoms of hyperthyroidism.

Are there any side effects?

All sources indicate that LDN has virtually no side effects. Occasionally, during the first week of use, patients may complain of difficulty sleeping. (Reports indicate that sleep disturbance is rare, occurring in less than 2% of users.)

LDN, in the low doses, is virtually non‐toxic, simple to administer, and, compared with other drug therapy, very inexpensive.

You'll find the rest of the information on LDN under the "About" Tab of the above named Facebook Page.

CategoryHealth & Medical
SensitivityNormal - Content that is suitable for ages 13+